SCHEMBL3055130

SCHEMBL3055130

COc1cccc(C(=O)N2CCc3cc(OCc4ccccc4)c(OC)cc3C2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.66
KMT2A Q03164 4/20 0.60
MEN1 O00255 2/20 0.60
MAPT P10636 2/20 0.59
LMNA P02545 2/20 0.59
CHRNA7 P36544 2/20 0.59
GPR183 P32249 1/20 0.58
MAPK1 P28482 1/20 0.58
NPC1 O15118 1/20 0.58
ABCB1 P08183 2/20 0.57
KDM4E B2RXH2 2/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
ALDH1A1 P00352 1/20 0.54
MDM2 Q00987 1/20 0.54
HCRTR2 O43614 3/20 0.54
GLA P06280 1/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3056795 0.92 KMT2A (0.62) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL3056740 0.90 KMT2A (0.68) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL9416605 0.89 LMNA (0.75) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL3054718 0.89 DRD2 (0.56) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL3041866 0.86 KMT2A (0.62) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL3046120 0.85 KMT2A (0.63) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL5125288 0.84 KMT2A (0.68) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL3056571 0.84 KDM4E (0.69) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL5127400 0.83 KMT2A (0.67) PDE4BKMT2AMEN1MAPTLMNA
SCHEMBL9667825 0.83 CHRNA7 (0.69) KMT2AMEN1MAPTCHRNA7GPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US claimed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed
EP-2155192-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS Sterix Limited (GB) 2010-02-24 EP disclosed
WO-2008117061-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS STERIX LIMITED (GB) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC PDE4B 1822/4885KMT2A 924/4885MEN1 305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.